With our leading technology platform, we are developing new small molecule medicines targeting cell membrane transporter proteins (known as solute carriers, SLCs), for patients battling critical diseases.
R&D:Solgate is a drug discovery company, focused on employing innovative technology to both de-risk target selection and develop chemical matter against solute carriers (SLCs). Through a platform approach, we chemically access in parallel multiple SLC targets , from which we develop discovery programs.
Plöcking 1, Klosterneuburg
Klosterneuburg
Lower Austria
Contact:
Telephone: 6642207581
Email: a.bensimon@solgatetx.com